| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |